YEA CHRISTOPHER (Chief Development Officer) sold 1.9% of their position (4.33K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $58.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/26/2025ACC: 0001691102-25-000006
Officer· Chief Development Officer
Since Sep 2018
-4.33K
Net shares
Net seller
$58.3K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
6.88K acquired · 11.21K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
1.7%
11/21/2025
220.96K→224.71K
Common Stock
Direct
Shares
+3.13K
Price / share
—
Trade value
—
% of position
1.4%
11/22/2025
224.71K→227.84K
Common Stock
Direct
Shares
−4.33K
Price / share
$13.45
Trade value
$58.26K
% of position
1.9%
11/24/2025
227.84K→223.51K
Total
Net shares
+2.54K
Net value
-$58.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | M · Option Exercise | +3.75K | — | — | 1.7% | 220.96K | 224.71K |
| Common Stock Direct | 11/22/2025 | M · Option Exercise | +3.13K | — | — | 1.4% | 224.71K | 227.84K |
| Common Stock Direct | 11/24/2025 | S · Sale | −4.33K | $13.45 | $58.26K | 1.9% | 227.84K | 223.51K |
| Total | +2.54K | -$58.26K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
48.75K
Exercisable
—
11/21/2025
Restricted Stock Unit
Direct
Converts to
Common Stock
3.13K shares
Shares
−3.13K
Strike price
Held after
31.25K
Exercisable
—
11/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.75K shares | 11/21/2025 | M · Option Exercise | −3.75K | — | 48.75K | |
| Restricted Stock Unit Direct | Common Stock3.13K shares | 11/22/2025 | M · Option Exercise | −3.13K | — | 31.25K |